In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

QR Code

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just
Format:	article
Langue:	EN
Publié:	AVES Yayincilik 2021
Sujets:	Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/b20e9e7443864b1fa7afc47c62c455d8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora
par: Stefan Winkler, et autres
Publié: (2021)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
par: Gia Deyab, et autres
Publié: (2021)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
par: Anne Mirjam Kerola, et autres
Publié: (2021)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
par: Kingsley GH, et autres
Publié: (2015)

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
par: Ivan Padjen, et autres
Publié: (2020)

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
par: Orme ME, et autres
Publié: (2012)

Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.
par: Christen Lykkegaard Andersen, et autres
Publié: (2014)

Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
par: Se Hee Kim, et autres
Publié: (2021)

Biologic monotherapy in the treatment of rheumatoid arthritis
par: Detert J, et autres
Publié: (2015)

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
par: Thao H P Nguyen, et autres
Publié: (2021)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
par: E. A. Golikova, et autres
Publié: (2012)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
par: Findeisen KE, et autres
Publié: (2021)

Single-Cell Transcriptome Profiles Reveal Fibrocytes as Potential Targets of Cell Therapies for Abdominal Aortic Aneurysm
par: Bolun Li, et autres
Publié: (2021)

Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
par: Manil Kukar, et autres
Publié: (2009)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
par: M. del Carmen Larios-Forte, et autres
Publié: (2021)

Assessment of depression, anxiety, stress, and quality of life in rheumatoid arthritis patients and comparison with healthy individuals
par: Aslam Khan, et autres
Publié: (2021)

Baricitinib for the treatment of rheumatoid arthritis
par: Ivan Urits, et autres
Publié: (2020)

Management of Rheumatoid Arthritis: An Overview
par: Andrei-Flavius Radu, et autres
Publié: (2021)

The prevalence of rheumatoid arthritis in Spain
par: Lucía Silva-Fernández, et autres
Publié: (2020)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

Infliximab in the treatment of rheumatoid arthritis
par: A Perdriger
Publié: (2009)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
par: Peter BB Jones, et autres
Publié: (2010)

Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
par: Fischer PA, et autres
Publié: (2018)

Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
par: Ditte Køster, et autres
Publié: (2021)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
par: I. A. Orlovskaya, et autres
Publié: (2015)

Genetics of rheumatoid arthritis: GWAS and beyond
par: McAllister KM, et autres
Publié: (2011)

Review of tocilizumab in the treatment of rheumatoid arthritis
par: Yasuaki Okuda
Publié: (2008)

The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020)

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
par: Codreanu C, et autres
Publié: (2015)

Temporomandibular joint problems in patients with rheumatoid arthritis
par: Teresa Sadura-Sieklucka, et autres
Publié: (2021)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021)

TELOMERE SHORTENING IN MONOCYTES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS
par: V. I. Borisov, et autres
Publié: (2014)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
par: V. V. Sokolova, et autres
Publié: (2014)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
par: T. Y. Abramova, et autres
Publié: (2014)

Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)

Rheumatoid Arthritis Onset from Shoulder Monoarthritis
par: Ishida K, et autres
Publié: (2021)

Rituximab therapy in Greek patients with rheumatoid arthritis
par: Haralampos M Moutsopoulos, et autres
Publié: (2008)

Frequency of sleep disorders in patients with rheumatoid arthritis
par: Mustafa M, et autres
Publié: (2019)

Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011)